Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mucuna Pruriens in Parkinson's Disease
NCT02680977Phase 2Completed
- Sponsor
- ASST Gaetano Pini-CTO
- Start
- Feb 2016
- Primary completion
- May 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of mucuna pruriens in Parkinson's disease (PD) (6 arms), sponsored by ASST Gaetano Pini-CTO. Primary endpoint: Magnitude of motor response at 3 hours. Started Feb 2016; status: completed.
02
Drugs
mucuna pruriens
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT02680977.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02680977.